Merck's COVID-19 pill effective against omicron in lab studies
>> Reuters
Published: 28 Jan 2022 06:17 PM BdST Updated: 28 Jan 2022 06:28 PM BdST
-
FILE PHOTO: An experimental COVID-19 treatment pill called molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021. Merck & Co Inc/Handout via REUTERS
Merck & Co Inc and partner Ridgeback Biotherapeutics said on Friday six lab studies showed their experimental oral COVID-19 drug molnupiravir was active against the fast-spreading omicron variant.
The data evaluated the antiviral activity of molnupiravir and other COVID-19 antiviral agents against COVID-19 variants of concern. Molnupiravir is yet to be studied against omicron in human studies, the companies said.
Molnupiravir and a rival oral pill from Pfizer Inc were authorised in the United States in December and are considered as important tools against omicron.
Pfizer said in December lab data suggested its drug Paxlovid retained its effectiveness against omicron.
Merck said earlier this month its pill has a mechanism that can work against omicron and any other variant.
Molnupiravir has been authorised for use in more than 10 countries, including the United States, United Kingdom and Japan.
-
Alert at airports to prevent monkeypox
-
WHO working on more monkeypox guidance
-
Puberty starts earlier than it used to. No one knows why
-
Monkeypox outbreak ‘largest ever’ in Europe
-
Britain offers shot as monkeypox cases spread in Europe
-
Why monkeypox cases are rising in Europe
-
World is in no better place to fight pandemics
-
Common medications can prolong back pain: study
-
Bangladesh issues alert at airports as Europe reports monkeypox cases
-
WHO working on more monkeypox guidance as cases rise: senior adviser
-
How concerned should we be about monkeypox?
-
Puberty starts earlier than it used to. No one knows why
-
Monkeypox outbreak in Europe ‘largest ever’ in region as cases cross 100
-
Britain offers smallpox shot as monkeypox cases spread in Europe
Most Read
- Reserves rise slightly past $42bn as Bangladesh scrambles to calm a dwindling currency market
- India jails trafficking suspect Ridoy Babo, 6 other Bangladeshis for life in rape case
- High Court denies 4 North South University trustees anticipatory bail, turns them over to police
- Woman attacked at Bangladesh railway station for her outfit
- Bangladesh issues alert at airports as Europe reports monkeypox cases
- Sentenced to 10 years in prison for wealth beyond means, MP Haji Salim lands in jail
- Slowly but steadily, Sylhet flooding begins to improve
- Bangladesh Bank devalues taka again as US dollar hits record high
- Victim of human-trafficking suspect Ridoy Babo returns to Bangladesh
- Maldives allows undocumented Bangladeshis to legalise status